| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.18B | 1.25B | 1.33B | 918.93M | 524.53M | 499.63M |
| Gross Profit | 732.10M | 775.72M | 825.88M | 574.89M | 312.25M | 303.12M |
| EBITDA | 489.55M | 295.55M | 741.80M | 666.71M | 326.30M | 323.19M |
| Net Income | -367.31M | -654.49M | -278.26M | 40.90M | 66.66M | 72.19M |
Balance Sheet | ||||||
| Total Assets | 9.86B | 10.65B | 12.64B | 13.85B | 4.26B | 3.81B |
| Cash, Cash Equivalents and Short-Term Investments | 43.34M | 68.92M | 25.70M | 60.96M | 13.18M | 15.30M |
| Total Debt | 4.72B | 4.96B | 5.30B | 5.70B | 1.92B | 1.71B |
| Total Liabilities | 5.11B | 5.35B | 5.71B | 6.17B | 2.07B | 1.86B |
| Stockholders Equity | 4.68B | 5.23B | 6.82B | 7.57B | 2.19B | 1.95B |
Cash Flow | ||||||
| Free Cash Flow | 219.16M | 252.64M | 268.79M | 109.20M | 131.94M | 376.13M |
| Operating Cash Flow | 462.77M | 501.62M | 499.82M | 272.75M | 232.63M | 470.09M |
| Investing Cash Flow | 603.00M | 900.92M | 349.14M | 1.63B | -562.47M | -555.17M |
| Financing Cash Flow | -1.05B | -1.36B | -884.22M | -1.86B | 327.72M | 99.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $8.11B | 27.08 | 8.13% | 3.56% | 59.25% | 88.37% | |
77 Outperform | $3.69B | 24.45 | 10.87% | 4.67% | 8.04% | 9.20% | |
77 Outperform | $4.70B | 25.92 | 6.29% | 6.37% | 8.12% | 75.95% | |
70 Neutral | $1.64B | 47.24 | 3.49% | 6.63% | 11.89% | -68.41% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
56 Neutral | $6.02B | -16.13 | -7.26% | 6.44% | -6.59% | 33.35% | |
55 Neutral | $2.95B | ― | -14.02% | 6.50% | 45.56% | 73.44% |
On December 17, 2025, Healthcare Realty Trust announced it entered equity distribution agreements and master forward confirmations with several financial firms for an equity offering program worth up to $1 billion. The move allows the company to issue Class A common stock and potentially engage in forward sale agreements to generate proceeds for general corporate purposes, including healthcare facility projects and debt repayment, reflecting a strategic step to secure capital for growth and strengthen its market positioning.
Healthcare Realty Trust reported a GAAP net loss of $0.17 per share for the third quarter of 2025, with Normalized FFO of $0.41 per share and a same-store cash NOI growth of 5.4%, driven by increased occupancy and tenant retention. The company executed leases totaling 1.6 million square feet and completed asset sales worth $404 million, with additional sales under contract, reflecting strategic market exits and property monetizations. The company also advanced its development and redevelopment projects, enhancing its portfolio in key markets. The board approved a dividend of $0.24 per share, and the company increased its guidance for Normalized FFO per share and same-store cash NOI growth for 2025.